Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver
Treatment and conditionWhere it standsTrials
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver for fatty liverPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver for liver cirrhosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver for liver failurePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1